You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Neomycin And Polymyxin B Sulfates And Hydrocortisone patents expire, and when can generic versions of Neomycin And Polymyxin B Sulfates And Hydrocortisone launch?

Neomycin And Polymyxin B Sulfates And Hydrocortisone is a drug marketed by Amring Pharms, Bausch And Lomb, and Sandoz. and is included in six NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
  • What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
  • What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amring Pharms NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 065216-001 Oct 31, 2005 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062874-001 May 11, 1988 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 064053-001 Dec 29, 1995 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 062423-001 Aug 25, 1983 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 062488-001 Nov 6, 1985 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amring Pharms NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 065219-001 May 1, 2006 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.